GPT Healthcare Limited Stock Price Today (NSE: GPTHEALTH)
Fundamental Score
GPT Healthcare Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
GPT Healthcare Limited share price today is ₹151.63, down 0.90% on NSE/BSE as of 1 September 2026. GPT Healthcare Limited (GPTHEALTH) is a Small-cap company in the Hospital sector with a market capitalisation of ₹1.25K (Cr). The 52-week high for GPTHEALTH share price is ₹175.00 and the 52-week low is ₹115.00. At a P/E ratio of 26.38x, GPTHEALTH is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 16.32% and a debt-to-equity ratio of 0.06.
GPT Healthcare Limited Share Price Chart — NSE/BSE Historical Performance
GPT Healthcare Limited share price chart: -9.68% return over the past month. 52-week high ₹175.00, 52-week low ₹115.00.
GPT Healthcare Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹151.06 | ₹152.00 | ₹148.66 | ₹149.92 | 85.35K (Cr) | |
| ₹153.32 | ₹154.54 | ₹151.48 | ₹153.13 | 76.60K (Cr) | |
| ₹156.04 | ₹156.98 | ₹154.01 | ₹156.15 | 66.66K (Cr) | |
| ₹157.50 | ₹159.78 | ₹153.55 | ₹154.98 | 1.84L (Cr) | |
| ₹160.90 | ₹160.94 | ₹156.09 | ₹157.28 | 71.28K (Cr) | |
| ₹157.00 | ₹162.00 | ₹153.91 | ₹160.51 | 1.58L (Cr) | |
| ₹159.44 | ₹160.59 | ₹156.61 | ₹157.14 | 87.15K (Cr) | |
| ₹165.70 | ₹165.70 | ₹157.47 | ₹159.44 | 1.80L (Cr) | |
| ₹164.50 | ₹167.63 | ₹163.09 | ₹165.03 | 1.22L (Cr) | |
| ₹164.59 | ₹165.00 | ₹161.11 | ₹164.70 | 1.32L (Cr) |
GPT Healthcare Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹169.64 | ₹172.35 | ₹148.66 | ₹149.92 | -11.62% | |
| ₹149.39 | ₹175.00 | ₹147.94 | ₹170.49 | +14.12% | |
| ₹141.20 | ₹156.00 | ₹141.02 | ₹148.51 | +5.18% | |
| ₹135.55 | ₹147.28 | ₹135.55 | ₹142.40 | +5.05% | |
| ₹119.70 | ₹141.50 | ₹115.00 | ₹138.43 | +15.65% | |
| ₹121.11 | ₹127.49 | ₹115.00 | ₹115.31 | -4.79% | |
| ₹128.00 | ₹135.89 | ₹121.40 | ₹126.26 | -1.36% | |
| ₹140.00 | ₹144.49 | ₹124.90 | ₹130.19 | -7.01% | |
| ₹143.10 | ₹144.80 | ₹132.30 | ₹140.35 | -1.92% | |
| ₹148.95 | ₹151.00 | ₹140.05 | ₹141.68 | -4.88% | |
| ₹147.86 | ₹153.90 | ₹145.29 | ₹148.64 | +0.53% | |
| ₹148.98 | ₹160.30 | ₹145.45 | ₹147.13 | -1.24% |
AI Research Briefing
Powered by Gemini · 2026-04-15
Eastern India healthcare play faces execution headwinds and management transition.
WHAT'S HAPPENING NOW (last 2-4 weeks)
GPT Healthcare announced the resignation of Mr. Debashis Dhar, Senior Vice President and Chief Business Development Officer, effective April 2, 2026, due to personal reasons. The company also submitted its Q4FY26 compliance certificate under SEBI regulations, reporting no dematerialization or rematerialization requests during the quarter.
CORE STORY (THE REAL GAME)
GPT Healthcare is a play on the rising demand for healthcare services in Eastern India, particularly leveraging its ILS Hospitals brand in a region with a growing need for quality healthcare and a rising influx of international patients. The focus is on expanding within Eastern India and capitalizing on strategic locations near transport hubs.
- Rising healthcare demand in Eastern India
- Strategic locations in dense residential areas
- Focus on operational efficiency
- Successful expansion in Eastern India
- Improvement in occupancy rates
- Effective cost management in newer facilities
- Small-cap liquidity risk
- Q3FY26 PAT declined 22% YoY
- Senior management exit
FII decreased holdings by 1.76%, DII decreased holdings by 2.88% [cite: brief].
Eastern India emerging as a hub for international patients.
Free Cash Flow 5Y: ₹222.08 Cr [cite: brief] suggests profit converting to cash.
Focus on improving occupancy and managing costs in newer facilities. Expansion in Eastern India remains key.
Primary Thesis Risk
Failure to improve occupancy and manage costs in newer facilities.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
GPT Healthcare Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
GPT Healthcare Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GPTHEALTH across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (16.32%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (18.14%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (21.32%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 26.38 vs Industry: 48.79)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (65.73%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (17.83%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.06)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (7.65x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹218.07 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Balanced Promoter Holding (65.57%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
Limited Institutional Interest (FII+DII: 9.65%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
GPT Healthcare Limited vs Hospital Peers
Peer Comparison - Hospital
Compare GPT Healthcare Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
GPT Healthcare LimitedGPT Healthcare ...Selected✓ GPTHEALTH • 544131 | 63/100 | ₹151.63₹152 | ₹1246.93₹1246.93 | 26.38Average 26.4 Average | 16.32%Good 16.32% Good | 18.14%Good 18.14% Good | 0.06Excellent 0.1 Excellent | — — | — — | 1.64% |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8889.00₹8889 | ₹128448.55₹128448.55 | 61.47Average 61.5 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1016.00₹1016 | ₹107422.79₹107422.79 | 73.71Average 73.7 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | — — | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹923.95₹924 | ₹73687.64₹73687.64 | 70.32Average 70.3 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | — — | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 37.2/100 | ₹765.25₹765 | ₹71917.90₹71917.90 | 225.67Average 225.7 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 68.3/100 | ₹1890.10₹1890 | ₹41592.95₹41592.95 | 50.96Average 51.0 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | — — | 25.05%Excellent 25.05% Excellent | 0.22% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 59.9/100 | ₹1404.40₹1404 | ₹35993.93₹35993.93 | 64.72Average 64.7 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.04% |
13.9/100 | ₹772.50₹773 | ₹33947.05₹33947.05 | 166.00Average 166.0 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 48.5/100 | ₹500.40₹500 | ₹15618.15₹15618.15 | 105.26Average 105.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | — — | — — | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 65.5/100 | ₹1445.20₹1445 | ₹15270.28₹15270.28 | 53.51Average 53.5 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | — — | — — | 0.23% |
60/100 | ₹298.70₹299 | ₹9829.95₹9829.95 | 52.28Average 52.3 Average | 13.41%Average 13.41% Average | 15.25%Good 15.25% Good | 0.33Excellent 0.3 Excellent | — — | — — | 0.07% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price128448.55 Cr
- Max Healthcare Institute Limited share price107422.79 Cr
- Fortis Healthcare Limited share price73687.64 Cr
- Aster DM Quality Care Limited share price71917.90 Cr
- Narayana Hrudayalaya Ltd. share price41592.95 Cr
GPT Healthcare Limited PE Ratio History
Historical price-to-earnings ratio for GPTHEALTH — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹6.08 | ₹140.35 | 23.1x |
| FY 2024 | ₹5.96 | ₹183.90 | 30.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
GPT Healthcare Limited Dividend History
Annual cash dividends paid by GPTHEALTH — dividend yield 1.64%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹28.72 Cr |
| FY 2024 | ₹23.97 Cr |
| FY 2023 | ₹31.96 Cr |
| FY 2022 | ₹17.26 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
GPT Healthcare Limited Quarterly Performance
Latest quarterly metrics for GPTHEALTH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
17.83%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
65.73%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
GPT Healthcare Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for GPTHEALTH — calculated from daily price history
Selling pressure is heavy — potential reversal zone.
Technical indicators are for educational purposes only. Not investment advice.
GPT Healthcare Limited Financial Statements
Annual income statement, balance sheet and cash flow for GPT Healthcare Limited (GPTHEALTH) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for GPT Healthcare Limited
About GPTHEALTH (GPT Healthcare Limited)
GPT Healthcare Ltd is a beacon of comprehensive care within the medical landscape, distinguished by its network of ILS Hospitals. These facilities are designed to provide a broad s...pectrum of medical services, attending to patients' diverse healthcare needs with a commitment to quality and patient-centricity. GPT Healthcare focuses on offering advanced diagnostic and therapeutic interventions, establishing itself as a trusted healthcare provider in its operational regions. The hospitals are staffed with skilled medical professionals, equipped with modern technology, and designed to create a healing environment, ensuring optimal patient outcomes. Within the walls of GPT Healthcare's ILS Hospitals, patients gain access to a coordinated array of specialized departments, each dedicated to specific areas of medicine. From the management of chronic conditions like diabetes by seasoned internists and diabetologists, to the intricate procedures performed by nephrologists, including life-saving renal transplants, GPT Healthcare displays a comprehensive approach to patient well-being. Complex laparoscopic and general surgeries are performed with precision, while the obstetrics and gynecology department provides complete care for women's health. The inclusion of critical care units emphasizes the organization's commitment to managing acute and severe illnesses with round-the-clock monitoring and immediate intervention. The range of services available at ILS Hospitals showcases GPT Healthcare's dedication to providing holistic healthcare solutions. Advanced procedures like robotic-assisted and bariatric surgery demonstrate a commitment to innovation and minimally invasive techniques. The cardiology department offers interventional procedures, while neurology and neurosurgery teams treat disorders of the nervous system. Pediatrics and neonatology departments are focused on the unique healthcare requirements of children and newborns. This comprehensive suite of services, combined with a focus on patient comfort and recovery, demonstrates GPT Healthcare's mission to improve lives through accessible and advanced medical care.
Company Details
Key Leadership
Corporate Events
GPTHEALTH Share Price: Frequently Asked Questions
What is the current share price of GPT Healthcare Limited?
GPT Healthcare Limited (GPTHEALTH) trades at ₹151.63 on NSE and BSE. Market cap ₹1.25K (Cr). Educational data only.
What is the P/E ratio of GPT Healthcare Limited?
GPT Healthcare Limited has a P/E of 26.38x vs industry average 48.79x.
What is the Bull Run score for GPT Healthcare Limited?
GPT Healthcare Limited has a Bull Run score of 63/100 based on 25+ financial parameters.
Does GPT Healthcare Limited pay dividends?
GPT Healthcare Limited has a dividend yield of 1.64%. Past dividends don't guarantee future payments.
What is the ROE of GPT Healthcare Limited?
GPT Healthcare Limited has ROE of 16.32%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of GPT Healthcare Limited?
GPT Healthcare Limited has debt-to-equity of 0.06.
Is GPT Healthcare Limited a good investment?
Bull Run gives GPT Healthcare Limited a score of 63/100. This is not investment advice — consult a SEBI-registered advisor.